Dr.Regine SITRUK WARE, Population Council, United States
Profile
Scopus
Educationđ
Paris University, Medical School, France,M.D., 1975, Medicine (Silver Medal),Specialist, 1976, Internal Medicine,Specialist, 1981, Reproductive EndocrinologyÂ
Experienceđ«
Dr. RĂ©GINE SITRUK-WARE currently serves as a Distinguished Scientist at the Population Council in New York, NY, where she has been pivotal in advancing reproductive health research and development. Her career spans roles in academia, industry, and international organizations, focusing on reproductive endocrinology and drug development.
Industry and International RolesÂ
Head of International Medical Affairs, Ciba-Geigy, Basle, Switzerland (1989-1995),Head of Research and Development, Theramex, Monaco (1995-1997),Head of Medicine, Research & Development, Exelgyn, Paris, France (1997-2000),Executive Director Research & Development, Population Council, New York, NY (2000-2010),Distinguished Scientist, Population Council, New York, NY (2010-present)
Skills
Dr. Sitrak-Ware’s expertise spans preclinical and clinical research, drug safety, and the development of reproductive health technologies. She has a strong background in leading multidisciplinary teams and managing international collaborations in the pharmaceutical and academic sectors.
Research Focus
Dr. Sitrak-Ware’s research focuses on:,Development of novel contraceptive technologies, including non-surgical permanent contraception.,Pharmacology and therapeutic potential of progestins, particularly in neuroprotection and myelin repair.,Non-oral delivery systems for hormonal therapies and contraceptives.
Publications
Dr. Sitrak-Ware has published extensively in peer-reviewed journals, contributing significant findings to the fields of reproductive endocrinology, contraceptive technologies, and pharmacology. Selected publications include:
- Chen S, Kumar N, Mao Z, Sitruk-Ware R, Brinton RD. Therapeutic progestin segesterone acetate promotes neurogenesis: implications for sustaining regeneration in female brain. Menopause. 2018;25(10):1138-1151.
- El-Etr M, Rame M, Boucher C, et al. Progesterone and nestorone promote myelin regeneration in chronic demyelinating lesions. Glia. 2015;63(1):104-117.
- Gemzell-Danielsson K, Sitruk-Ware R, Creinin MD, et al. Segesterone acetate/ethinyl estradiol 12-month contraceptive vaginal system safety evaluation. Contraception. 2019;99(6):323-328.
- Brache V, Vieira CS, Plagianos M, et al. Pharmacodynamics and pharmacokinetics of a copper intrauterine contraceptive system releasing ulipristal acetate: A randomized proof-of-concept study. Contraception. 2021;104(4):327-336.